Advitech merges its operations with Botaneco while closing a **$2.5 million equity financing round**. The company also appoints a **new President and Chief Executive Officer** to lead the combined entity. The merger integrates Advitech’s existing business with Botaneco’s operations, expanding its focus in the environmental technology sector.
The TSX Venture Exchange approves the consolidation of Advitech Inc.’s shares as part of its merger with Botaneco. The move follows Advitech’s announcement of the operational combination, though no further details on the transaction terms or timeline have been disclosed. Both companies operate in the life sciences sector, with Advitech specializing in medical devices and Botaneco in cannabis research and production.
Advitech Inc. completes the consolidation of its common shares following the merger of its operations with Botaneco. The transaction is finalized in escrow, pending regulatory or operational conditions. The move integrates Advitech’s business activities under a unified structure, though specific terms or next steps remain unstated in the announcement.
Nov 2009newswire.caNews article
AgeChem Venture Fund
AgeChem Venture Fund is a therapeutics investment fund that invests in companies developing therapeutics for age-related diseases.
